Danaher (NYSE:DHR) PT Raised to $153.00 at Piper Jaffray Companies
Danaher (NYSE:DHR) had its target price hoisted by research analysts at Piper Jaffray Companies from $148.00 to $153.00 in a research note issued on Thursday, The Fly reports. The brokerage presently has a “neutral” rating on the conglomerate’s stock. Piper Jaffray Companies’ price objective points to a potential upside of 6.99% from the stock’s previous close.
A number of other analysts have also recently commented on the stock. Zacks Investment Research cut shares of GALP ENERGIA SG/ADR from a “hold” rating to a “sell” rating in a research report on Monday, May 6th. Janney Montgomery Scott increased their target price on Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a report on Wednesday, April 17th. Wolfe Research assumed coverage on Waters in a report on Thursday, May 30th. They set an “underperform” rating for the company. Finally, Needham & Company LLC reiterated a “buy” rating and set a $150.00 target price (up previously from $135.00) on shares of Veeva Systems in a report on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $133.38.
Shares of DHR stock traded up $3.35 during trading hours on Thursday, reaching $143.00. The company had a trading volume of 4,519,858 shares, compared to its average volume of 2,673,210. The firm’s 50 day simple moving average is $140.06. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18. The firm has a market capitalization of $100.11 billion, a price-to-earnings ratio of 31.64, a price-to-earnings-growth ratio of 2.70 and a beta of 0.96. Danaher has a 1-year low of $94.59 and a 1-year high of $145.50.
In other news, SVP William King sold 12,950 shares of the stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the completion of the transaction, the senior vice president now directly owns 29,070 shares in the company, valued at approximately $3,776,774.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Angela S. Lalor sold 3,091 shares of the stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $132.23, for a total transaction of $408,722.93. Following the transaction, the senior vice president now owns 38,515 shares of the company’s stock, valued at $5,092,838.45. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 453,448 shares of company stock valued at $59,724,640. Company insiders own 11.40% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Norges Bank acquired a new stake in Danaher in the 4th quarter valued at about $747,082,000. Jennison Associates LLC acquired a new stake in Danaher during the first quarter worth approximately $489,930,000. Railway Pension Investments Ltd acquired a new stake in Danaher during the second quarter worth approximately $13,030,000. Marshall Wace North America L.P. lifted its position in Danaher by 48.5% during the first quarter. Marshall Wace North America L.P. now owns 2,115,438 shares of the conglomerate’s stock worth $279,281,000 after acquiring an additional 690,837 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in Danaher by 8.4% during the fourth quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock worth $774,743,000 after acquiring an additional 583,194 shares during the last quarter. Institutional investors own 78.82% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: What is the strike price in options trading?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.